Our Pipeline
|
Candidate
|
Preclinical
Precl
|
Phase 1
Ph1
|
Phase 2
Ph2
|
Phase 3
Ph3
|
Approved
Appd
|
| ||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Thyroid Eye Disease
|
||||||||||
|
Veligrotug
Anti-IGF-1R
|
Veligrotug
Anti-IGF-1R
|
Approved in the U.S.
| ||||||||
|
Elegrobart
Anti-IGF-1R
|
Elegrobart
Anti-IGF-1R
|
| ||||||||
|
|
| |||||||||
|
Autoimmune Diseases
|
||||||||||
|
VRDN-006
Anti-FcRn
|
VRDN-006
Anti-FcRn
|
| ||||||||
|
VRDN-008
Anti-FcRn
|
VRDN-008
Anti-FcRn
|
| ||||||||